🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cyclosporine A (CsA) is a common long-term treatment used to inhibit the im...
Status
Completed
Location
University of Minnesota, ACTU
Start Date
2004-02
Trial ID
NCT00084149
Treatments Being Tested
The purpose of this study is to 1. Compare and evaluate the single-dose bi...
Status
Completed
Location
Veeda clinical research Pvt. Ltd., India
Start Date
2007-02
Trial ID
NCT01136525
Treatments Being Tested
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Start Date
2017-07-26
Trial ID
NCT02952508
Treatments Being Tested
Cancer is a condition where cells in a specific part of body grow and repro...
Status
Terminated
Location
Fort Wayne Medical Oncology and Hematology, Inc /ID# 224332
Start Date
2020-05-05
Trial ID
NCT04272203
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The main purpose of this study is to compare the effectiveness of Human Reg...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-02
Trial ID
NCT01774968
Treatments Being Tested
The purpose of this study is to investigate whether PEG-rhGH with new prepa...
Status
Not Yet Recruiting
Location
Chengdu Xinhua Hospital
Start Date
2025-05
Trial ID
NCT06840691
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404